Literature DB >> 8338525

An international comparison of case definition of severe adverse cutaneous reactions to medicines.

R S Stern1, E Albengres, J Carlson, D Chen, C Kreft, W Dai, M Joseph, H Tilson, B E Wiholm, C Kraft.   

Abstract

There is substantial intercountry variation in the proportion of cases of toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS) which are attributed to specific drugs. This study was undertaken to determine whether these differences might reflect biases in diagnosis of these conditions. A total of 138 reactions in 5 countries originally diagnosed as TEN or SJS were coded on to standardised forms. A single observer blind to the original diagnosis assessed each case according to specified criteria. This observer's diagnoses were compared with the original diagnoses. Overall, 111 of the 138 cases had information adequate for assessment. The blinded observer agreed with the diagnosis for 61% of cases where the original diagnosis was TEN and 58% of cases where the original diagnosis was SJS. There was no significant difference in rates of agreement when reactions attributed to sulphonamide antibiotics were compared with reactions attributed to other drugs. There were substantial and significant differences in percentage agreement between the blinded observer's diagnosis and the original diagnoses between countries. The lowest rates of agreement between the blinded observer and the original reports occurred in the US. Our results illustrate the difficulty in comparing reaction rates based on spontaneous reports between countries where the systems for gathering such reports vary. This illustrates the need for a minimum quantity of standard data and precise definitions of reactions if spontaneous reports of adverse reactions are to provide useful information about severe adverse skin reactions associated with drugs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8338525     DOI: 10.2165/00002018-199308010-00008

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  9 in total

1.  Physician reporting of adverse drug reactions. Results of the Rhode Island Adverse Drug Reaction Reporting Project.

Authors:  H D Scott; A Thacher-Renshaw; S E Rosenbaum; W J Waters; M Green; L G Andrews; G A Faich
Journal:  JAMA       Date:  1990-04-04       Impact factor: 56.272

2.  An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use.

Authors:  M S Kramer; J M Leventhal; T A Hutchinson; A R Feinstein
Journal:  JAMA       Date:  1979-08-17       Impact factor: 56.272

3.  Adverse drug reaction monitoring: doing it the French way.

Authors:  N Moore; M Biour; G Paux; E Loupi; B Begaud; F Boismare; R J Royer
Journal:  Lancet       Date:  1985-11-09       Impact factor: 79.321

4.  The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients.

Authors:  H L Chan; R S Stern; K A Arndt; J Langlois; S S Jick; H Jick; A M Walker
Journal:  Arch Dermatol       Date:  1990-01

5.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

6.  Toxic epidermal necrolysis. Granulocytic leukopenia as a prognostic indicator.

Authors:  E D Westly; H L Wechsler
Journal:  Arch Dermatol       Date:  1984-06

7.  The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome).

Authors:  J C Guillaume; J C Roujeau; J Revuz; D Penso; R Touraine
Journal:  Arch Dermatol       Date:  1987-09

8.  Toxic epidermal necrolysis. A step forward in treatment.

Authors:  D M Heimbach; L H Engrav; J A Marvin; T J Harnar; B J Grube
Journal:  JAMA       Date:  1987-04-24       Impact factor: 56.272

Review 9.  Adverse reactions to isotretinoin. A report from the Adverse Drug Reaction Reporting System.

Authors:  M Bigby; R S Stern
Journal:  J Am Acad Dermatol       Date:  1988-03       Impact factor: 11.527

  9 in total
  2 in total

1.  Serious skin reactions and selective COX-2 inhibitors: a case series from prescription-event monitoring in England.

Authors:  Deborah Layton; Vanessa Marshall; Andrew Boshier; Peter Friedmann; Saad A W Shakir
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 2.  Pharmacogenetics of drug hypersensitivity.

Authors:  Elizabeth J Phillips; Simon A Mallal
Journal:  Pharmacogenomics       Date:  2010-07       Impact factor: 2.533

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.